Constitutive activation of signal transducer and activator of transcription 3 in epithelial ovarian carcinoma
- 23 October 2009
- journal article
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 35 (5), 918-925
- https://doi.org/10.1111/j.1447-0756.2009.01045.x
Abstract
To investigate the expressions of signal transducer and activator of transcription 3 (Stat3) and tyrosine-activated Stat3 (p-Stat3) in epithelial ovarian carcinoma (EOC) and their relationships with clinical pathological parameters or prognosis. Immunohistochemical methods were used to detect the expressions of Stat3 and p-Stat3 in EOC, benign ovarian tumors and normal ovarian tissues, after which an analysis of results with clinical pathological or prognosis was given. The expressions of Stat3 and p-Stat3 in EOC were significantly higher than in normal ovarian epithelial tissues or benign ovarian tumor tissues (P < 0.0125) and the expression of Stat3 protein was highly correlated with the expression of p-Stat3 protein (P < 0.01). The positive rate of Stat3 in stages of III and IV (96.9%) was significantly higher than in stages of I and II (72.2%) (P < 0.05). Meanwhile, p-Stat3 expression was significantly correlated with disease stage, degree of differentiation and lymph node metastasis. Along with higher clinical stage (P < 0.05), p-Stat3 expression was gradually increased. The p-Stat3 expression was negatively correlated with the prognosis of EOC patients (P < 0.01). Overexpression and overactivation of Stat3 was found in EOC tissues, and the constitutive activation of Stat3 signaling pathway may play an important role in the invasion and prognosis of EOC.Keywords
This publication has 17 references indexed in Scilit:
- Stat3 activation in human endometrial and cervical cancersBritish Journal of Cancer, 2007
- The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosisCancer, 2006
- Activated Epidermal Growth Factor Receptor–Stat-3 Signaling Promotes Tumor SurvivalIn vivoin Non–Small Cell Lung CancerClinical Cancer Research, 2005
- Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasisOncogene, 2004
- What does Stat3 do?JCI Insight, 2002
- Constitutive activation of STAT transcription factors in acute myelogenous leukemiaEuropean Journal of Haematology, 2001
- Constitutive Activation of Stat 3 Oncogene Product in Human Ovarian Carcinoma CellsGynecologic Oncology, 2000
- STATs in oncogenesisOncogene, 2000
- Stat3 as an OncogeneCell, 1999
- Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src OncoproteinScience, 1995